Skip to main content
NVS logo
NVS
(NYSE)
Novartis AG
$154.03-- (--)
Loading... - Market loading

Novartis (NVS) Income Statement

Revenue, expenses, profit margins, and earnings with annual and quarterly data.

Novartis Income Statement Analysis

Revenue, earnings, and profit margins in billions USD

Scroll to see more
Novartis AG income statement - Annual data in billions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period EndingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Revenue & Gross Profit
Revenue56.6751.7246.6643.4643.9749.9048.6846.1043.40
Cost of Revenue13.7012.8312.4711.5811.7415.1214.4314.5113.63
Gross Profit42.9838.9034.1931.8832.5834.7834.2531.5929.77
Operating Expenses
Research & Development11.2010.0211.379.178.648.989.408.498.39
Selling, General & Administrative13.2512.5712.5212.1912.8314.2014.3713.7212.47
Operating Expenses25.3324.3523.9522.6721.6224.6325.1723.1921.07
Operating Income17.6414.5410.239.2110.9610.159.098.408.70
Other Income/Expense
Interest Income0.370.57-0.01-0.0115.340.090.250.290.11
Interest Expense1.141.01-0.86-0.80-0.790.920.900.970.80
Other Income/Expense-0.31-0.220.00-0.01-0.03-0.27-0.155.690.40
Income
Income Before Tax16.3513.649.127.1824.539.888.9414.109.10
Income Tax Expense2.391.700.551.131.631.811.791.301.60
Net Income13.9811.9414.856.9624.028.0711.7312.617.70
Net Income - Continuous Operations13.9711.948.576.9624.028.0711.7312.617.70
Net Income - Discontinued Operations0.000.006.280.910.000.000.000.000.00
EBITDA22.8220.729.777.9510.0617.2115.6220.2414.59
EBIT17.5014.659.777.9510.060.000.000.000.00
Depreciation & Amortization5.336.077.924.734.676.465.835.214.74
Earnings Per Share
Basic EPS7.006.007.003.0010.004.003.005.003.00
Diluted EPS7.006.007.003.0011.004.003.005.003.00
Basic Shares Outstanding1.942.022.082.182.242.282.292.322.35
Diluted Shares Outstanding1.962.042.092.202.262.302.322.342.37

These financial metrics are calculated using income statement data. Learn how each metric works and screen stocks by them.